Nuscale Power earnings missed by $0.02, revenue fell short of estimates
Cathie Wood’s ARK ETF published their daily trades for Tuesday, August 5th, 2025, showcasing a strategic shift in their investment portfolio. The most significant transaction of the day was the purchase of 181,295 shares of CRISPR THERAPEUTICS AG (NASDAQ:CRSP) through its ARKK ETF, with a total dollar value of $10,803,369. This move underscores ARK’s continued confidence in the gene-editing company, marking a trend as the fund also sold a smaller number of CRSP shares the previous Monday.
ARK also made a substantial sell-off of ROBLOX CORP (PRE-REINCORPORATION) (NYSE:RBLX) stock, parting with 42,703 shares through its ARKK ETF, valued at $5,581,282. This trade follows a pattern of reducing their position in Roblox, as seen in trades from the previous week, indicating a possible strategic pivot away from the gaming platform’s shares.
In addition, ARK bought 288,331 shares of AURORA INNOVATION INC (NASDAQ:AUR) through its ARKQ ETF, amounting to $1,718,452. This purchase adds to their holdings from the previous day, suggesting a growing interest in the autonomous vehicle company.
The sale of BLADE AIR MOBILITY INC (NASDAQ:BLDE) shares also featured prominently in ARK’s trading activity. The fund sold a total of 259,619 shares across its ARKQ and ARKX (NYSE:ARKX) ETFs, totaling a dollar value of $1,150,112. This continues the selling trend from Monday, where ARK divested a significantly larger number of BLDE shares.
Other notable trades included the acquisition of INTUITIVE MACHINES INC (NASDAQ:LUNR) shares, with a combined purchase of 144,675 shares through ARKQ and ARKX ETFs, valued at $1,620,360. This follows a previous buy on Monday, suggesting ARK’s increasing interest in the lunar exploration company.
Smaller trades of the day involved buying TERADYNE INC (NYSE:TER) and KASPI.KZ AO (LSE:KSPI) shares, as well as the purchase of TWIST BIOSCIENCE CORP (NASDAQ:TWST) shares, which ARK has been accumulating over recent days.
The fund’s trading decisions reflect a dynamic approach to investment, with an eye on both cutting-edge biotechnology firms and innovative companies in other sectors. Investors and market watchers alike will be keeping a close eye on ARK’s future moves, as these daily trades offer insights into the strategic thinking of one of the market’s most closely watched fund managers.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.